Culmination Bio

Saint George, United States

Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.

$10.0M raised

Nov 2023

Series A

Biotechnology Health Care

Top Investors

EPIC VenturesMerck Global Health Innovation FundAmgen Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Culmination Bio

How much funding has Culmination Bio raised?

Culmination Bio has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in November 2023.

Who are Culmination Bio's investors?

Culmination Bio's investors include EPIC Ventures, Merck Global Health Innovation Fund, Amgen Ventures.

Where is Culmination Bio headquartered?

Culmination Bio is headquartered in Saint George, United States.

What does Culmination Bio do?

Culmination Bio is a startup that is developing a disease-independent patient data intelligence platform.

What stage is Culmination Bio at?

Culmination Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 30, 2023.

MLA

"Culmination Bio — Funding & Investors." VCBacked, November 30, 2023, https://www.vcbacked.co/company/culmination-bio. Accessed June 17, 2026.

APA

VCBacked. (2023). Culmination Bio — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/culmination-bio

Wikipedia (cite web)

{{cite web |title=Culmination Bio — Funding & Investors |url=https://www.vcbacked.co/company/culmination-bio |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 30, 2023.

Similar Companies in Biotechnology